Literature DB >> 1138631

Influence of increased circulating levels of splanchnic lysosomal enzymes on the response to myocardial ischemia.

J A Spath, E A Reed, A M Lefer.   

Abstract

The ability of increased circulating activities of lysosomal hydrolases to disrupt myocardial cellular membranes was studied in anesthetized cats. Increased activities of lysosomal hydrolases were achieved by splanchnic artery occlusion (SAO) shock or by infusion of liver extract (LE). Myocardial ischemia (MI) was produced by ligation of the left coronary artery. Coronary artery ligation resulted in sustained S-T segment elevation associated with significant increases in plasma creatine phosphokinase (CPK) activity within 5 hours. Combinations of SAO or LE infusion did not modify the increase in either the plasma CPK activity or the S-T segment following MI. However, SAO shock or infusion of LE increased CPK loss from normal and ischemic myocardium, the loss being greater when MI was combined with infusion of LE or SAO shock. Similarly, MI plus SAO shock increased the loss of the lysosomal protease cathepsin D from normal and ischemic myocardial tissue. Moreover, cats subjected to MI and given LE inhibited increased mortality and decreased clearance of infused lysosomal hydrolases. These results indicate that conditions affecting increased plasma levels of hydrolases promote increased disruption of normal and ischemic myocardial tissue. These findings are consistent with the concept that hydrolases originating in the splanchnic viscera during shock play a role in enhancing damage to normal and ischemic myocardial tissue following coronary artery occlusion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138631      PMCID: PMC1343900          DOI: 10.1097/00000658-197506000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Pancreatic perfusion in the pathophysiology of hemorrhagic shock.

Authors:  J A Spath; R J Gorczynski; A M Lefer
Journal:  Am J Physiol       Date:  1974-02

2.  Time course of enzyme escape via heart lymph following myocardial infarction in the dog.

Authors:  P Malmberg
Journal:  Scand J Clin Lab Invest       Date:  1972-12       Impact factor: 1.713

3.  Disappearance of intravenously infused acid hydrolases from the circulation in pigs.

Authors:  P E Fredlund; P A Ockerman; J O Vang
Journal:  Acta Chir Scand       Date:  1973

4.  Myocardial lysosome stability in the early stages of acute ischemic injury.

Authors:  M A Ricciutti
Journal:  Am J Cardiol       Date:  1972-10       Impact factor: 2.778

5.  Circulatory responses to splanchnic lysosomal hydrolases in the dog.

Authors:  T M Glenn; A M Lefer; A C Beardsley; W W Ferguson; A M Lopez-Rasi; T S Serate; J R Morris; S L Wangensteen
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

6.  Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit.

Authors:  J K Kjekshus; B E Sobel
Journal:  Circ Res       Date:  1970-09       Impact factor: 17.367

7.  Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats.

Authors:  T M Glenn; A M Lefer
Journal:  Circ Res       Date:  1970-11       Impact factor: 17.367

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

9.  Changes in the activities of lysosomal enzymes in infarcted canine heart muscle.

Authors:  K G Ravens; S Gudbjarnason
Journal:  Circ Res       Date:  1969-06       Impact factor: 17.367

10.  Presence of a myocardial depressant factor in patients in circulatory shock.

Authors:  W L Lovett; S L Wangensteen; T M Glenn; A M Lefer
Journal:  Surgery       Date:  1971-08       Impact factor: 3.982

View more
  2 in total

1.  Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.

Authors:  S E Burke; A M Lefer; G M Smith; J B Smith
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Plasma acid phosphatase levels in endotoxaemia: modification by drugs and chemically detoxified endotoxins.

Authors:  D V Godin; J M Tuchek
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.